Streetbeat News

Products Services

VCYT

Veracyte, Inc. (NASDAQ:VCYT) announced new data from a phase 3 trial that reinforces the value of the Decipher Prostate Genomic Classifier in helping physicians make more informed treatment decisions for their patients with prostate cancer. The findings were presented at the 2023 American Society for Radiation Oncology (ASTRO) Annual Meeting. A second study presented at the meeting revealed minimal to moderate risk-score correlation between three commercially available genomic classifiers, suggesting that the level of evidence supporting each genomic test should drive utilization.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 8:12 pm

RVMD

Revolution Medicines, Inc. (NASDAQ:RVMD) announced it will present new clinical data for two of its RAS(ON) Inhibitors at the 2023 AACR-NCI-EORTC International Conference and the 2023 European Society for Medical Oncology Congress. The company will also host an investor webcast to review the clinical data presentations and discuss the company's overall pipeline and strategy.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 8:11 pm

GRTS

Gritstone Bio has announced presentations from Phase 1 studies evaluating its next-generation vaccine candidate for COVID-19 at IDWeek 2023.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 8:10 pm

ASLE

BA

AerSale is nearing the conclusion of the FAA certification process for its enhanced flight vision system, AerAware, which is applicable to the Boeing 737NG and MAX aircraft.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 8:09 pm

KRON

Kronos Bio will present interim data from the Phase 1 dose escalation portion of its ongoing Phase 1/2 KB-0742 study at the AACR-NCI-EORTC conference. The company will also host a virtual investor event on October 13.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 8:06 pm

NOC

Voyager Space has announced a teaming agreement with Northrop Grumman to develop autonomous docking technology for Northrop Grumman's Cygnus spacecraft and provide cargo resupply services for the Starlab space station. The space station will be built and operated under a joint venture between Voyager Space and Airbus Defence and Space. The companies will also explore opportunities to strengthen the development of Starlab and the enhanced Cygnus system to serve NASA's Commercial Low-Earth Orbit Development program.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 8:05 pm

OMGA

Omega Therapeutics will present new preclinical data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 8:01 pm

ETHUSD

MATICUSD

Wire Network has opened its decentralized MegaMask wallet for alpha testing. The wallet allows users to send, receive, and buy cryptocurrency across platforms such as Wire Network, Polygon, and Ethereum. The wallet also introduces social features and aims to sidestep the high fees associated with the Ethereum blockchain. The company aims to develop a system that fosters trustless transactions over multiple blockchains, eliminating the need for third-party bridges or oracles.

Portfolio Pulse from Murtuza Merchant

October 04, 2023 | 7:59 pm

AMZN

Amazon is reportedly shutting down its live audio app, Amp, according to a Bloomberg post.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 7:46 pm

NVAX

The FDA has granted emergency use authorization to Novavax Inc's COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) for individuals aged 12 and older. The approval comes at a time when the demand for COVID-19 vaccines is increasing. Novavax has a contracted price of $72.5/dose with the CDC and a price of $130/dose subject to insurance/pharmacy-level rebates and discounts. Despite the positive news, NVAX shares are down 6%.

Portfolio Pulse from Vandana Singh

October 04, 2023 | 7:19 pm